Alaska

Integrated Kidney Partners VIII LLC

Primary Contact

Ryan Pardo
Ryan.Pardo@usrenalcare.com


KCE Participants

Dialysis Facilities

AD Partners II LLC
Alaska Dialysis – Laurel Street, LLC
Liberty Dialysis – Alaska LLC

Practices

Kidney and Hypertension Clinic of Alaska Inc

Adrienne Johnson Sarah Bilak Larson
Amala Kanury Shannon Yoder
Benjamin Lawson Shuang Ying Bao
Jeremy Gitomer Stephanie McQuillin
Osman Yilmam Rahul Abraham
Thuy-Trang Ngo

Dialysis Associates of Alaska, LLC

Amala Kanury Stefano Emil
David Lefler Thuy-Trang Ngo
Jeremy Gitomer Osman Yilmam
Rahul Abraham

Nephrology & Hypertension Associates of Alaska PC

David Lefler Sarah Bilak Larson

Aurora Kidney LLC

Christine Walrath Roy Uyeno
Stefano Emil

Mogilishetty PLLC

Gautham Mogilishetty

Vijay Vidyasagar

Vijay Vidyasagar

Preferred Providers

Practice Provider Name
Western Psychological and Counseling Services LLC
Psycare Inc
Kidney and Hypertension Clinic of Alaska Inc Erica Mucha

Joint Ventures

There are no joint ventures between or among the KCE and any of its KCE Participants and Preferred Providers.


Administrative Lead

Name Employer
Mike Flood U.S. Renal Care

Clinical Lead

Name Employer
Dr. Stefano Emil Aurora Kidney, LLC

KCE Governing Body Members

Name Employer / Stakeholder Group
Jeremy Gitomer Kidney and Hypertension Clinic of Alaska
Gautham Mogilishetty Mogilishetty PLLC
Stefano Emil Aurora Kidney, LLC
Michael Rocklin U.S. Renal Care
Mike Flood U.S. Renal Care
April Schroeder U.S. Renal Care
Susan Safford U.S. Renal Care
Julie Gonzalez U.S. Renal Care
Lori Hartwell Renal Support Network

Shared Savings and Shared Losses Information

a. Gross Savings/Losses BEFORE CMS withholds:
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: $4,805,650

b. The amount of Shared Savings or Shared Losses, net of CMS Withholds and Aggregation:
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: $1,460,648

c. The proportion of Shared Savings invested in infrastructure, redesigned care processes, and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries; and
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: 98%

d. The proportion of Shared Savings distributed to KCE Participants and Preferred Providers
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: 2%

8. The KCE’s performance on the quality measures used to calculate the KCE’s TQS, as described in the Quality Overview Document and Measure Specifications Document.
Total Quality Score (TQS) results out of 100%, based on KCE quality measure performance during the period
Performance Year 2023 TQS: 100%
Performance Year 2024 TQS: 88.75%
Earned High Performance Pool designation

9. Total Program Income to Participants (QCP, Transplant Bonus, Home Bonus, other income)
PY2023 Ancillary Income will be reported in 2026 when final reconciliations are released by CMS.
PY2024: $929,297